Quoin Pharmaceuticals, Ltd. (QNRX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-07) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-26) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | 8-K (2025-05-14) · 99.1 | ||
| 10-Q | Q1-2025 | — | ||
| 10-K | FY-2024 | 8-K (2025-03-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-08) · 99.1 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | 8-K (2024-03-13) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-11-09) · 99.1 | 8-K (2023-08-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Balance Sheets(P) | — |
|
| Consolidated Statements of Operations | ||
| Consolidated Statements of Operations and Other Comprehensive Loss | ||
| Consolidated Statements of Shareholders' Equity | ||
| Consolidated Statements of Shareholders' Equity (deficit) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | ||
| Accrued Interest and Financing Expense | ||
| Award Timing Disclosure | — |
|
| Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value of Financial Instruments | ||
| Financing | — |
|
| In-licensed Technology | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | ||
| License Agreements | ||
| Liquidity Risks and Other Uncertainties | ||
| Organization and Business | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses | — |
|
| Prepaid Expenses and Other Current Assets | — |
|
| Related Party Transactions | ||
| Research Agreements and Commitments | — |
|
| Research, Consulting Agreements and Commitments | ||
| Shareholders' Equity | ||
| Stock Based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||